Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In violation of Dale's principle several neuronal subtypes utilize more than one classical neurotransmitter. Molecular identification of vesicular glutamate transporter three and cholecystokinin expressing cortical interneurons (
CCK
+
VGluT3
+
INTs) has prompted speculation of GABA/glutamate corelease from these cells for almost two decades despite a lack of direct evidence. We unequivocally demonstrate
CCK
+
VGluT3
+
INT-mediated GABA/glutamate cotransmission onto principal cells in adult mice using paired recording and optogenetic approaches. Although under normal conditions, GABAergic inhibition dominates
CCK
+
VGluT3
+
INT signaling, glutamatergic signaling becomes predominant when glutamate decarboxylase (GAD) function is compromised.
CCK
+
VGluT3
+
INTs exhibit surprising anatomical diversity comprising subsets of all known dendrite targeting
CCK
+
interneurons in addition to the expected basket cells, and their extensive circuit innervation profoundly dampens circuit excitability under normal conditions. However, in contexts where the glutamatergic phenotype of
CCK
+
VGluT3
+
INTs is amplified, they promote paradoxical network hyperexcitability which may be relevant to disorders involving GAD dysfunction such as
schizophrenia
or vitamin B6 deficiency.
...
PMID:Paradoxical network excitation by glutamate release from VGluT3
+
GABAergic interneurons. 3205 7
<< Previous
1
2
3